Could the risks of cholesterol-lowering statins outweigh the benefits? Is the research on these drugs fatally biased, as it was funded and carried out by statin manufacturers in a way that would be "totally unacceptable" today?
That's what a new study claims. The UK Queen's former doctor is calling for an independent inquiry - and here's what UK cardiologist Dr. Aseem Malhotra says:
Express: 'We Are Very Worried' Former Royal Doctor Demands Statins Inquiry JCBMR: Beyond Confusion and Controversy, Can We Evaluate the Real Efficacy and Safety of Cholesterol-Lowering with Statins?These are truly disturbing findings and fit in with the concept that all industry-sponsored studies should be seen as marketing until proven otherwise.
19 1:02:45
